...r Reddy's or Cipla or even Teva for that matter? Big ticket domestic consolidations have eluded the Indian pharmaceutical industry. But maybe not for soon. Malvinder Singh, MD & CEO of Ranbaxy ...
a year ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Rajesh Jain of SMC Global Securities is of the view that in Natco Pharma one can keep Rs 80 as a stoploss. It has support at around Rs 80-85. One can exit the stock at Rs 110-115.
9 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Natco Pharma has cracked the technology to develop Teva's multiple sclerosis drug Copaxone, which has US sales of over USD 2 billion, reports CNBC-TV18. The drug is marketed by Sanofi Aventis. Natco has tied up with a US generic company Mylan for mar...
7 months ago
moneycontrol.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to: